Wistron MedTech Officially Launches BestShape® VS Night Partners with Medical and Industry Leaders to Build a Sleep Health Ecosystem

Taiwan’s First Class II Medical Device Utilizing Millimeter-Wave Radar Achieves 96% Accuracy in Identifying Severe OSA

TAIPEI, Taiwan — Wistron MedTech hosted the “BestShape® VS Night AI Contactless Sleep Management System Launch and Sleep Health Expert Symposium” today (30th), officially introducing BestShape® VS Night to the Taiwan market. Combining millimeter-wave (mmWave) radar sensing with AI analysis, the system allows users to conduct sleep monitoring at home without wearing any devices and receive a comprehensive sleep analysis report the following morning. As Taiwan’s first Class II medical device certified mmWave radar sleep monitoring product, BestShape® VS Night has completed clinical validation, demonstrating a 96% accuracy rate in identifying severe Obstructive Sleep Apnea (OSA) and showcasing significant potential for home sleep monitoring applications.

The event featured distinguished guests from both medicine and industry, including Dr. Li-Pang Chuang, President of the Taiwan Society of Sleep Medicine; Prof. Wen-Te Liu from the Department of Respiratory Therapy and Thoracic Medicine at Taipei Medical University; Prof. Ning-Hung Chen from Chang Gung University; Dr. Li-Chuan Fang, Director of the Sleep Center and Otolaryngologist at Fu Jen Catholic University Hospital; as well as industry partners Chang-Chi Ko, Chairman, and Hsien-Jen Hsieh, Vice President of Sinphar Pharmaceutical Co., Ltd. (Sintong Chemical Industry Co., Ltd.). Together, they exchanged insights on sleep care, clinical applications, and industry development to explore opportunities for integrating medical and industrial resources to progressively build a sleep health care ecosystem.

Wistron MedTech gathered sleep medicine experts, clinicians, and industry representatives for cross-sector exchanges to jointly explore the clinical applications of home sleep monitoring and development opportunities for the sleep healthcare ecosystem.

Taiwan’s First Class II Medical Device Utilizing mmWave Radar Demonstrates Smart Healthcare Capabilities

According to the white paper “From Hospital to Home: Focusing on the New Era of OSA Sleep Care” published jointly by the Taiwan Society of Sleep Medicine and PwC, only about 10% of OSA patients in Taiwan are estimated to be diagnosed and treated. This highlights that a vast majority of potential patients have yet to enter the professional healthcare system, underscoring the vital importance of early sleep health awareness and seamless connection with professional medical care.

BestShape® VS Night utilizes mmWave radar technology combined with AI big data analytics to track sleep metrics and generate analytical reports completely non-invasively—without touching the body or disrupting the daily routines of the user or their bed partner. Users simply place the device bedside, point it toward their chest area during sleep, and connect it to power and Wi-Fi to begin monitoring. The next day, users can view their sleep data via computer or smartphone and track night-to-night trends over time, establishing a continuous and comparable home sleep database to serve as a reference for personal sleep management and subsequent medical consultations.

Qun-Ying Hsieh, General Manager of Wistron MedTech, stated: “Wistron MedTech is dedicated to becoming a leading brand in smart medical technology solutions. The official launch of BestShape® VS Night demonstrates our strength in translating innovative technology into clinical applications. By partnering with Sintong, a leader in Taiwan’s pharmaceutical industry, we combine our advantages in smart medical technology and healthcare resources. Through the Yung-Ding Sleep Center partner network, we plan to progressively roll out this product to hospitals and clinics across northern, central, and southern Taiwan, bringing innovative technology directly into healthcare settings and creating greater value for integrated sleep healthcare.”

Looking ahead, BestShape® VS Night is expected to collaborate with thoracic medicine, dentistry, psychiatry, and weight-loss clinics to explore opportunities for integrating home sleep monitoring with professional medical evaluations and follow-up care.

Qun-Ying Hsieh, General Manager of Wistron MedTech, shared the product features and vision for BestShape® VS Night, showcasing Wistron MedTech's strategic direction in building a sleep healthcare ecosystem.

Sleep Health Management: Moving from Early Identification to Long-Term Tracking

Dr. Li-Pang Chuang, President of the Taiwan Society of Sleep Medicine, noted: “Sleep issues affect not only daily life but can also pose long-term health risks. Convenient, low-interference monitoring tools combined with professional medical evaluation and long-term tracking can help the public spot abnormalities early, shifting sleep care from passive medical treatment to proactive management.”

Dr. Li-Pang Chuang, President of the Taiwan Society of Sleep Medicine, shared the current state of sleep healthcare in Taiwan, discussing early risk identification and long-term health management for Obstructive Sleep Apnea (OSA).

96% Accuracy in Identifying Severe OSA Highlights the Potential of Contactless Sleep Monitoring

Prof. Wen-Te Liu from the Department of Respiratory Therapy and Thoracic Medicine at Taipei Medical University shared: “BestShape® VS Night has completed preliminary clinical validation, achieving a 96% accuracy rate in identifying severe OSA. This highlights the strong potential of non-contact technology in detecting sleep-disordered breathing risks. However, data accuracy, stability, and clinical evidence remain key benchmarks for evaluating technology. While this data serves as a valuable reference for follow-up professional medical evaluations, it does not replace a physician’s diagnosis.”

Prof. Wen-Te Liu from the Department of Respiratory Therapy and Thoracic Medicine at Taipei Medical University shared the clinical research and validation results of BestShape® VS Night, discussing the potential of non-contact sleep monitoring technology in OSA risk identification.

Dr. Li-Chuan Fang, Director of the Sleep Center and Otolaryngologist at Fu Jen Catholic University Hospital, remarked: “Many people are unaware of their breathing conditions during sleep and often only start paying attention when they experience daytime fatigue or are alerted by family members. Home sleep monitoring provides an accessible alternative for understanding sleep patterns. If integrated with professional medical assessments and follow-up tracking in the future, it will help bring sleep health management much closer to everyday life.”

Dr. Li-Chuan Fang, Director of the Sleep Center and Otolaryngologist at Fu Jen Catholic University Hospital, shared practical testing experiences with BestShape® VS Night, exploring the application opportunities and future development directions of home sleep monitoring in clinical care.

Connecting Medical and Industrial Resources to Expand Sleep Health Applications

Beyond clinical research and medical applications, another major focus of the event was how to integrate industry resources to make sleep health management more accessible in daily life. Wistron MedTech and Sintong plan to utilize the sleep medical partner network established by Sintong’s subsidiary, Yung-Ding Biotech, to gradually introduce BestShape® VS Night to medical institutions across northern, central, and southern Taiwan. This initiative aims to bridge home sleep monitoring, professional medical evaluation, and follow-up care services, bringing innovative technology from clinical validation to actual healthcare delivery settings.

Moving forward, Wistron MedTech will continue to deepen R&D and clinical applications for BestShape® VS Night. Through ongoing clinical studies and real-world validations, the company aims to explore risk stratification and diagnostic triage applications for various severities of sleep apnea, helping healthcare providers utilize sleep examination resources more efficiently. Starting with Taiwan, Wistron MedTech will also evaluate international market opportunities to expand the application of contactless sleep monitoring across diverse medical and home care settings.